19-28z CAR T cells: Phase I data

A Phase I trial in patients with poor-risk, relapsed/refractory aggressive Beta cell

Read the full 129 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE